NCT05451212 2025-11-10Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia GravisCabaletta BioPhase 1 Completed7 enrolled
NCT05737160 2025-05-23Study of Telitacicept in Generalized Myasthenia GravisRemeGen Co., Ltd.Phase 3 Completed114 enrolled